Scisparc Ltd
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About SPRC
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Find out what a historical investment in Scisparc Ltd would be worth today using our SPRC stock calculator.
$6.03M
-
0.00%
168.56K
$2.02
$1.83
$1.99
$37.59
$1.55
Ready to start your investing journey with Stake?
Open an accountSPRC FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SPRC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SPRC
on Stake
Buy SPRC from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of SPRC from only US$10 with fractional shares
